JCIA
BMY icon

Jackson Creek Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Jackson Creek Investment Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$379K Buy
5,800
+70
+1% +$4.02K 0.13% 286
2026
Q1 		$348K Buy
+5,730
New +$334K 0.1% 270
2023
Q2 		– Sell
-6,024
Closed -$418K – 313
2023
Q1 		$418K Buy
+6,024
New +$425K 0.18% 264
2020
Q4 		– Sell
-4,807
Closed -$290K – 308
2020
Q3 		$290K Buy
+4,807
New +$289K 0.13% 273

Other funds holding BMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jackson Creek Investment Advisors's BMY Position: Q2 2026 in Review

Jackson Creek Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 1.2% in Q2 2026, buying an estimated $4.02K and bringing the position to 5,800 shares worth $379K. The position accounts for 0.13% of the portfolio, ranked #286.

Jackson Creek Investment Advisors first reported a position in BMY in Q3 2020 and has held it in 4 quarters since. The position peaked at $418K in Q1 2023. 2,531 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Jackson Creek Investment Advisors held 5,800 shares of Bristol-Myers Squibb worth $379K as of Q2 2026.
  • Jackson Creek Investment Advisors bought 70 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.02K.
  • Bristol-Myers Squibb made up 0.13% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #286 holding.
  • Jackson Creek Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 4 quarters since.
  • Jackson Creek Investment Advisors's Bristol-Myers Squibb position peaked at $418K in Q1 2023.
  • 2,531 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.